Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites/Experiment 1/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/03/21

Curator: Omojokunoluwatomisin

Revision editor(s): Omojokunoluwatomisin

Source: figure 2b

Description: Gut microbial composition in lung cancer patients(C) and benign diseases patients(N). (B) Differential taxa at the genus level analyzed by linear discriminant analysis (LDA) scores (LDA > 2.0, P < 0.05)

Abundance in Group 1: increased abundance in lung cancer

NCBI	Quality Control	Links
Anaerobutyricum hallii
Bifidobacterium
Bacteroides

Revision editor(s): Omojokunoluwatomisin